Accumulation of fat mass in obesity may result from hypertrophy and/or hyperplasia and is frequently associated with adipose tissue (AT) dysfunction in adults. Here, we assessed early alterations in AT biology and function by comprehensive experimental and clinical characterization of 171 AT samples from lean and obese children aged 0 to 18 years.
Evidence of early alterations in adipose tissue biology and function and its association with obesity-related inflammation and insulin resistance in children
Obesity is characterized by the accumulation of fat mass and is often associated with adipose tissue (AT) dysfunction (1) . Clinical data indicate that obesity already develops during early childhood between 2 and 6 years of age (2) . Expansion of AT can be achieved by hyperplasia (increase in adipocyte number) or hypertrophy (increase in adipocyte size) or the combination of both (3) . Early studies suggested that adipocyte number is determined in childhood and remains relatively constant during adulthood implying that expansion of AT mass in (adult) obesity occurs via hypertrophy of adipocytes (4;5) . On the other hand, the capability for cell renewal, achieved by differentiation of preadipocytes into mature adipocytes, persists throughout life (6) . Whether AT expansion in the development of obesity occurs primarily by hyperplasia or hypertrophy and the time point when AT dysfunction emerges are still a matter of debate.
In addition to the mere accumulation of fat mass, obesity is often associated with changes in AT biology and function including adipocyte cell death, autophagy, hypoxia, altered adipokine profile, remodeling of the extracellular matrix, and inflammation (7) . This AT dysfunction is hypothesized to be a major contributor to the adverse metabolic and cardiovascular consequences of obesity seen clinically (8) . Particularly macrophage infiltration into AT and the ensuing orchestrated inflammatory response appear to play a role in the development of obesity-associated insulin resistance and cardiovascular disease (9;10).
Noteworthy, obesity-related comorbidities including insulin resistance, hypertension, and dyslipidemia, are already evident in children and adolescents (2;11).
So far, most studies focusing on obesity-associated AT dysfunction have been performed in adults. Considering the fact that obesity and the occurrence of first related comorbidities develop as early as in childhood (2) , studies in children might allow better insight into the early processes occurring with normal development and progression of obesity at the level of AT. In addition, children usually represent earlier stages of disease and studying the underlying mechanisms is less biased by pre-existing comorbidities and their treatment.
The aim of this work was to evaluate obesity-associated alterations in AT biology in children and to evaluate their association with clinical parameters. In particular, we wanted to test the hypothesis that AT accumulation in childhood obesity is primarily associated with adipocyte hypertrophy and leads to AT inflammation and whether these alterations are linked to the early emergence of clinical comorbidities in children. Fasting blood samples were obtained prior to surgery. Levels of adiponectin, leptin, high sensitivity C-reactive protein (hsCRP), tumor necrosis factor alpha (TNFalpha), interleukin-6 (IL-6), glucose and insulin were measured by a certified laboratory. HOMA-IR (homeostasis model assessment of insulin resistance) was calculated to evaluate insulin resistance (14) .
RESEARCH DESIGN AND METHODS

Subjects and samples (Leipzig
Implausible values were excluded from the analysis (leptin≤0.2ng/ml).
Isolation of adipocytes and cells of the stromal vascular fraction (SVF) from human AT samples
Following excision during surgery, subcutaneous AT samples were washed three times in phosphate buffered saline (PBS 
Lipolytic capacity of isolated adipocytes
50µl of freshly isolated adipocytes were diluted in 250µl of serum-free medium (DMEM/F12, 0.8% BSA) with or without 10µM isoproterenol for 20h (18;19) . The amount of glycerol released into the media was determined using Free Glycerol Reagent (Sigma). Lipolytic activity was normalized to adipocyte number determined by the Coulter counter method and is given as the release of glycerol in ng/ml per 1000 adipocytes.
Immunohistochemical analyses
Tissue samples were fixed in 4% paraformaldehyde, paraffin-embedded, and sectioned (12µm). Immunohistochemical stainings were performed with a monoclonal CD68 antibody
(1:500; M0718, DAKO) using the DAKO REAL™ APAAP Immunocomplex system according to the manufacturer's protocol.
RNA isolation and mRNA expression analyses
RNA isolation and quantitative real-time PCR from whole AT samples or isolated SVF cells were performed as previously described (15) . Primer and probe sequences are listed in Supplementary table 1.
Statistical analyses
Data that did not adhere to Gaussian distribution were log-transformed before analyses. 
RESULTS
General characteristics of patients and samples of our Leipzig Childhood Adipose Tissue cohort are summarized in Table 1 . Study participants in the lean and obese subgroups were not different with respect to gender distribution and pubertal stage, although obese children were older than lean children (Table 1) .
Adipocyte size and number are related to accumulation of AT in children
We addressed the controversially discussed question whether fat accumulation is a result of hypertrophy and/or hyperplasia by evaluating potential associations of adipocyte size and total adipocyte number with AT accumulation (5;20;21) . Compared to lean controls, adipocyte size and total adipocyte number were significantly increased in obese children by 17.2% and 164%, respectively (Table 1 ) and correlated with obesity-related parameters, such as BMI SDS (Fig.1A ,B) and AT mass (Fig.1C,D) . Both, adipocyte size and total adipocyte number increased with age in the lean subgroup (Fig.1E,F) . The adipocyte size, but not adipocyte number, also correlated with age in the obese subgroup (Fig.1E,F) .
For further analyses, we stratified children into age groups representing distinct stages of childhood development: 0-2yr (infancy), 3-5yr (early childhood), 6-8yr (prepubertal), 9-11yr (beginning of puberty), 12-15yr (puberty), and 16-19yr (adolescence) . Adipocytes from obese children were larger than adipocytes from non-obese children in all age groups starting from the age of six (Fig.1G ). In normal-weight children adipocyte size increased from early childhood to adolescence and adulthood. In obese children, adipocyte size at 6-8yr was already significantly increased and then remained relatively constant until early adulthood, indicating that adipocyte size may reach a plateau at childhood age, which is higher in obese children ( Fig.1G ). In all age groups, we observed an approximately two-fold increase in total adipocyte number in obese compared to lean children (Fig.1H ). In both lean and obese children adipocyte number appeared to plateau from 9-11yr onwards, potentially indicating that individual adipocyte number is determined by this age. There were no significant gender differences in adipocyte size or number between lean females and males (data not shown).
In multiple regression analyses, we confirmed total adipocyte number and adipocyte size as independent predictors for AT mass accounting for 68% and 3% of waist circumference variability, respectively ( Table 2) . We selected waist circumference because, besides BMI, it is considered to be a good index of adiposity in children, but is mathematically not directly related to variables in the model. Similar results were obtained for AT mass (Table 2) .
Proliferation but not differentiation of SVF cells is enhanced in obese children
The observed increase in adipocyte number may result from enhanced proliferation of adipogenic progenitor cells and subsequent differentiation into mature adipocytes. We The slope of cell number increase in cell culture appeared to be more steep in obese compared to lean children, leading to a 5-fold higher cell number at day 10 post seeding in obese children ( Fig.2A ). In line with this, SVF cell doubling time was accelerated in obese children (Table 1 ) and correlated negatively with BMI SDS (Fig.2B ). There was no association of SVF cell doubling time with age in the whole cohort (Fig.2C ) or in lean children only (R=0.157, p=0.547). Furthermore, SVF cell doubling time was not related to adipocyte size ( Fig.2D , Table 3 ).
The percentage of differentiated SVF cells was not different in obese compared to lean children ( Table 1 , Fig.2E ) or in samples of small adipocytes compared to large adipocytes (Table 3) as documented by similar levels of Oilred O absorbance ( 
Enhanced macrophage infiltration in AT of obese children
To assess inflammation in AT of children, we investigated the infiltration of macrophages into AT and the relationship with adipocyte size. The number of CD68 + macrophages was doubled in obese children compared to lean children (Table 1 ) and there was a weak but significant positive correlation with BMI SDS (Fig.3A) and age (Fig.3B ). When we restricted correlation analyses to lean children only, the association between macrophage number and age was lost (R=0.177, p=0.100). Similar results were obtained for CD68 expression ( Table   1 ). As adipocyte hypertrophy is hypothesized to drive macrophage infiltration (10;20), we analyzed the relationship between adipocyte size and number of CD68 + macrophages, and confirmed a positive association (Fig.3C ). When we stratified AT samples in tertiles according to adipocyte size, we observed a 3-fold increase in macrophage number in samples containing large adipocytes compared to samples containing small adipocytes (Table 3) .
We further documented enhanced AT inflammation in obese children by significantly increased presence of crown-like structures (CLS, CD68 + macrophages surrounding an adipocyte; Fig.3D ), which we found in almost half of the obese children but in less than 10% of the lean children (Table 1 ). In addition, the presence of CLS increased with adipocyte size (Table 3) .
Next, we analyzed the relation of macrophage infiltration in AT to inflammatory markers such as hsCRP, TNFalpha, or IL-6. We observed significantly increased hsCRP serum levels in obese compared to lean children (Table 1) . However, obese children did not show increased TNFalpha or IL-6 serum levels nor TNFalpha or IL-6 expression in AT (Table 1) .
In correlation analyses, macrophage number was not clearly associated with hsCRP (R=0.165, (Table 3) .
Basal lipolysis is decreased in adipocytes of obese children
Next, we characterized metabolic function of adipocytes by assessing the lipolytic activity of isolated adipocytes. We observed a significant decrease in basal lipolytic activity in obese compared to lean children ( Table 1 , Fig.4A ). Stimulation with the β-agonist isoproterenol led to a significant increase of lipolytic activity in adipocytes of both, lean and obese children (Fig.4A ). However, there was no significant difference in the magnitude of isoproterenolstimulated lipolytic activity between the two groups ( Table 3 ), which was, however, lost after adjustment for BMI SDS (R=-0.11, p=0.643). Neither basal nor stimulated lipolytic activity changed with age in the whole cohort (Fig.4D ) or in the lean subgroup (R=-0.059, p=0.863).
Adipocyte hypertrophy is linked to increased leptin serum levels and insulin resistance
Finally, we evaluated serum levels of the adipokines adiponectin and leptin for their association with obesity-related alterations in adipocyte biology.
As expected, we observed decreased adiponectin serum levels in obese compared to lean children and a negative association of adiponectin with BMI SDS (Table 1 , Fig.5A ) and age (R=-0.503, p<0.001). Adiponectin levels did not differ between samples with small or large adipocytes (Table 3) , nor did they show a correlation with adipocyte size (Fig.5B) or number (R=-0.311, p=0.875). However, we observed a negative association with macrophage infiltration (Fig.5C ), the presence of CLS (11.03±0.83ng/ml vs. 
p<0.001).
Serum leptin was positively correlated to the degree of obesity in children (Table 1 , Fig.5D ), and age (R=0.477, p<0.001). Furthermore, leptin levels significantly increased with adipocyte size (Fig.5E , Table 3 ), number of macrophages (Fig.5F ), presence of CLS (9.99±1.70ng/ml vs. 28.44±4.65ng/ml in children with or without CLS, p<0.001), and hsCRP serum levels (R=0.591, p<0.001). Adipocyte size was the strongest predictor for leptin levels in multivariate analyses ( Fig.5G ), age (R=0.634, p<0.001), but also adipocyte size (Fig.5H ), and were 4-fold higher in samples of patients containing large adipocytes compared to small adipocytes (Table 3 ). In addition to the association with adipocyte hypertrophy, HOMA-IR was related to macrophage infiltration (Fig.5I) Unexpectedly, we detected a negative association of HOMA-IR and TNFalpha serum levels (R=-0.396, p<0.001). In multivariate analyses, HOMA-IR was most strongly affected by adipocyte hypertrophy (Table 2) .
DISCUSSION
In this study we show that adipocyte number and adipocyte size increase with the accumulation of fat mass in normal lean children. Obese children already present adipocyte hypertrophy and hyperplasia starting from early childhood onwards. Particularly adipocyte hypertrophy is associated with increased macrophage infiltration and presence of CLS in AT.
AT dysfunction in obese children directly corresponds to alterations in adiponectin and leptin serum levels and the insulin resistance marker HOMA-IR.
In humans, AT mass increases from birth to adolescence with two periods of accelerated accumulation in early childhood and puberty. Biologically, AT accumulation can be achieved
by an increase in cell number and/or an enlargement of existing adipocytes. We show an increase in adipocyte size and particularly in number with age in normal lean children from 3-5 years onwards. Our data complement earlier studies in children suggesting two time intervals which are important in ontogenetic development of AT. Before the age of two, cell size increases rapidly, while there is a weaker increase in adipocyte number, and during adolescent growth spurt when non-obese subjects reach adult cell size and cell number increases (4;22).
So far, it is not completely clear, when deviation from this normal dynamic of AT expansion occurs in the development of obesity, and whether this is driven by hypertrophy or hyperplasia (7). Both, adipocyte size and total adipocyte number were already considerably higher in obese children aged 6 years and increased with the degree of obesity in our cohort indicating that both hypertrophic and hyperplastic AT growth contribute to the development of obesity in children. Interestingly, total adipocyte number was the strongest predictor of AT mass in children.
Major processes involved in the formation of new and more adipocytes are proliferation and differentiation from progenitor cells residing within the SVF of AT (23) . In line with other studies (24), we show that the number of adherent/proliferating cells was not different in SVF of obese compared to lean children. In contrast, the proliferation rate and in vitro doubling time of SVF cells were increased in obese children in close relation to the degree of obesity.
Similarly, a positive correlation between BMI and proliferative capacity of subcutaneous adipose progenitor cells was shown in humans (25) and in response to high fat diet in rodents (20;26;27) . According to current hypotheses, proliferation of progenitors is enhanced when critical achievable adipocyte cell size is reached in order to permit further expansion of AT (28) . From our study, we cannot provide evidence for a potential direct association of proliferative capacity of progenitor cells and adipocyte size. In contrast to the enhanced proliferation rate, we did not observe alterations in the differentiation potential of SVF cells in obese children. This is in line with some studies in adults (29;30), whereas another study showed that differentiation of subcutaneous preadipocytes inversely correlates with the degree of obesity (31) .
One limitation of our study is that our experimental approach was based on the cell number of adherent SVF cells as opposed to preselected preadipocytes. Hence, we cannot draw a direct conclusion about preadipocyte proliferation and differentiation rate. Reassuringly, however, previous studies showed that adipose progenitor cells are the most abundant subpopulation comprising 67.9% of cells within the SVF of human subcutaneous AT. Moreover, they
showed that these cells have the highest proliferation and differentiation capacity compared to all other populations (32).
The remodeling capacity of AT through hypertrophy and hyperplasia is physiologically important to respond to alterations in energy balance. The pathological acceleration of AT remodeling in the obese state (7) is associated with a myriad of effects such as hypoxia, cell death, altered adipokine profile, and inflammation and contributes to the clinical adverse consequences of obesity (8) . Particularly AT inflammation is regarded as a major pathological factor (10;33). We observed that obesity-associated macrophage infiltration into subcutaneous AT is already enhanced in young children, similarly to what has been described before (34) .
Moreover, the characteristic arrangement of macrophages into CLS occurs as early as 6 to 8 years of age. This has been shown for adults (34) (35) (36) Altered metabolism, particularly lipolysis, is another sign of AT dysfunction (7) and may contribute to the increase in AT mass during development of childhood obesity (7;39). In adults, basal lipolytic activity was shown to be enhanced (40;41) and the lipolytic effect of catecholamines to be decreased in obesity (42) (43) (44) . In contrast to adult studies, we found a decreased basal lipolytic activity in adipocytes of obese children but a preserved response to catecholamines. Our data do, however, complement clinical studies on lipid mobilization in children in vivo showing lower lipolytic activity of AT in obese children (39) , which may contribute to AT hypertrophy in obesity.
We were finally interested how the alterations in AT biology we found experimentally relate to adipokine serum levels and first obesity-related clinically adverse phenomenons (2;11). In addition to well-known obesity-related alterations in leptin and adiponectin (45;46), both, leptin and adiponectin were associated with inflammatory AT and serum parameters.
However, only leptin showed an independent correlation with adipocyte size and may hence indicate adipocyte hypertrophy.
We furthermore identified strong and independent associations of enlarged adipocyte size with HOMA-IR, indicating that the vicious link between adipocyte hypertrophy and insulin resistance (47) is already effective in childhood.
One potential bias considering the serum parameters may derive from the sampling immediately after anesthesia has been started in the patients. Previous studies on propofol and fentanyl did not provide consistent evidence for an effect on leptin levels (48;49), and the confirmation of expected associations of leptin levels with obesity were reassuring in our study. A major limitation of our study is the restriction to subcutaneous AT depots. Other depots were unfortunately not accessible due to the nature and site of surgery. Particularly, visceral fat samples would be desirable as this is discussed as a profound risk factor for development of obesity-associated diseases, such as insulin resistance and diabetes (33) .
Furthermore, the sometimes small samples volumes of <1g did not permit to perform more detailed functional analyses, which would have been desirable to allow conclusions on the pathomechanism. Finally, determination of body composition based on skinfold measurements and HOMA-IR both represent accepted but not ideal markers for insulin resistance in children. Using more sophisticated measurements for body composition and insulin resistance and/or additional measures related to insulin resistance, such as highmolecular-weight adiponectin rather than total adiponectin levels (50), was not feasible in our study but might be of interest for future studies. Nevertheless, we believe that our study provides new insights into the early alterations in AT biology in early obesity in children.
Here, we show that obesity-associated AT dysfunction occurs early in life and is characterized by hypertrophy and hyperplasia in AT, which was particularly accompanied by increased inflammation. This AT dysfunction is already linked to clinical low-grade inflammation and insulin resistance in obese children.
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